Quarterly report pursuant to Section 13 or 15(d)

Balance Sheets (Unaudited)

v3.22.2.2
Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Current assets    
Cash $ 17,187,890 $ 27,204,269
Acquired patents, net 10,809 12,615
Total assets 17,198,699 27,216,884
Current liabilities    
Accounts payable & accrued interest 220,845 220,845
Unreimbursed expenses 8,289 164,327
Total current liabilities 229,134 385,172
Total liabilities 229,134 385,172
Stockholders’ equity    
Common stock, $0.001 par value; 100,000,000 shares authorized; 12,774,809 and 13,147,829 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively 12,775 13,148
Additional paid-in capital 53,320,020 60,466,093
Accumulated deficit (36,363,230) (33,647,529)
Total stockholders’ equity 16,969,565 26,831,712
Total liabilities and stockholders’ equity $ 17,198,699 $ 27,216,884